GSEA also further confirmed the plausibility of the PPI results, e.g. ABL protein enrichment in the pancreatic adenocarcinoma pathway, pancreatic cancer, CPB1 enrichment in the metabolism of angiotensinogen to angiotensins, and peptide hormone metabolism. The gene discussed is AGT; the disease is pancreatic neoplasm.